1. Home
  2. AQMS vs ITRM Comparison

AQMS vs ITRM Comparison

Compare AQMS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$5.41

Market Cap

20.9M

Sector

Industrials

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.37

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQMS
ITRM
Founded
2014
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
24.3M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
AQMS
ITRM
Price
$5.41
$0.37
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$9.00
AVG Volume (30 Days)
135.5K
731.7K
Earning Date
11-12-2025
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.37
$0.36
52 Week High
$39.40
$2.10

Technical Indicators

Market Signals
Indicator
AQMS
ITRM
Relative Strength Index (RSI) 38.29 33.37
Support Level $5.96 $0.44
Resistance Level $7.61 $0.49
Average True Range (ATR) 0.55 0.04
MACD -0.17 0.00
Stochastic Oscillator 3.19 3.75

Price Performance

Historical Comparison
AQMS
ITRM

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: